Search research articles
Contact Us
Filters
Showing results (451-460 of 466) with videos related to
Page
of 47
Sort By:
Cancer Discovery
|
November 25, 2020
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease
Daniel V T Catenacci, Stephanie Moya, Samantha Lomnicki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2021
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors
Corey C Foster, Gini F Fleming, Theodore G Karrison, et al.
JNCI Cancer Spectrum
|
January 11, 2021
IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405
Brendan J Guercio, Sui Zhang, Fang-Shu Ou, et al.
JAMA Network Open
|
January 9, 2024
Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial
Hannah M Thompson, Dana M Omer, Sabrina Lin, et al.
The Lancet. Oncology
|
February 23, 2017
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
Van K Morris, Mohamed E Salem, Halla Nimeiri, et al.
JAMA Network Open
|
February 15, 2020
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial
Daniel V T Catenacci, Leah Chase, Samantha Lomnicki, et al.
Science Translational Medicine
|
August 5, 2011
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA
Scott A Tomlins, Sheila M J Aubin, Javed Siddiqui, et al.
Ebiomedicine
|
September 25, 2024
Crowd-sourced machine learning prediction of long COVID using data from the National COVID Cohort Collaborative
Timothy Bergquist, Johanna Loomba, Emily Pfaff, et al.
Annals of Surgery
|
August 7, 2025
Real-world Monitoring of ctDNA Reliably Predicts Cancer Recurrence and Treatment Efficacy in Patients with Resected Stages I-III Colon Cancer
Stacey A Cohen, Vasily N Aushev, George Laliotis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2022
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy
Julio Garcia-Aguilar, Sujata Patil, Marc J Gollub, et al.
Page
of 47
Search research articles
Search
Showing results (451-460 of 466) with videos related to
Sort By:
Page
of 47
Cancer Discovery
|
November 25, 2020
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease
Daniel V T Catenacci, Stephanie Moya, Samantha Lomnicki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2021
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors
Corey C Foster, Gini F Fleming, Theodore G Karrison, et al.
JNCI Cancer Spectrum
|
January 11, 2021
IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405
Brendan J Guercio, Sui Zhang, Fang-Shu Ou, et al.
JAMA Network Open
|
January 9, 2024
Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial
Hannah M Thompson, Dana M Omer, Sabrina Lin, et al.
The Lancet. Oncology
|
February 23, 2017
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
Van K Morris, Mohamed E Salem, Halla Nimeiri, et al.
JAMA Network Open
|
February 15, 2020
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial
Daniel V T Catenacci, Leah Chase, Samantha Lomnicki, et al.
Science Translational Medicine
|
August 5, 2011
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA
Scott A Tomlins, Sheila M J Aubin, Javed Siddiqui, et al.
Ebiomedicine
|
September 25, 2024
Crowd-sourced machine learning prediction of long COVID using data from the National COVID Cohort Collaborative
Timothy Bergquist, Johanna Loomba, Emily Pfaff, et al.
Annals of Surgery
|
August 7, 2025
Real-world Monitoring of ctDNA Reliably Predicts Cancer Recurrence and Treatment Efficacy in Patients with Resected Stages I-III Colon Cancer
Stacey A Cohen, Vasily N Aushev, George Laliotis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2022
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy
Julio Garcia-Aguilar, Sujata Patil, Marc J Gollub, et al.
Page
of 47